A study published in JAMA raises concerns about the US Army's mandatory low testosterone screening program. The research suggests that up to a quarter of active-duty Army members could receive a low testosterone result, significantly higher than the actual prevalence of the condition.
Defense Secretary Pete Hegseth announced the mandatory screening in July, with clinical guidance released in September. Medical organizations like the Endocrine Society and the American Urological Association have advised against such blanket screenings due to risks of unnecessary medical evaluations, inaccurate results, and potential harm, including infertility.
Researchers from the Pennington Biomedical Research Center and the US Army Research Institute of Environmental Medicine conducted the study. They analyzed data from a military health survey, including morning blood draws from 479 male, active-duty Army service members.
The study's sample was statistically weighted to represent the active-duty US Army personnel, with a mean age of approximately 30 years and a mean BMI of 28.4, categorized as 'overweight'.
The findings highlight the reasons why testosterone levels are typically not measured in asymptomatic men. The study suggests that the new mandatory screenings could ensnare a large number of Army members in clinically dubious evaluations, leading to potential overtreatment and adverse health outcomes.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's briefNew every morning, and the back catalogue is archived by date.
A JAMA study indicates that mandatory low testosterone screenings for active-duty Army members, announced by Defense Secretary Pete Hegseth, could result in up to 25% receiving a low testosterone result. Medical experts warn this could lead to unnecessary evaluations, inaccurate diagnoses, and potential harm, including infertility, despite professional recommendations against blanket screenings.